India is the world’s largest producer of the anti-malaria drug, hydroxychloroquine, and it’s making more of it in response to endorsements from President Donald Trump. Dr. Shriprakash Kalantri of the Mahatma Gandhi Institute of Medical Sciences in Maharashtra tells host Marco Werman the drug is not a “magic bullet” and asks why fellow Indians are also promoting it.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.